Given the significant side effects of current Alzheimer’s treatments, targeting tyrosinase inhibition might offer a dual therapeutic strategy not only for skin aging but also for slowing the progression of Alzheimer’s disease. This evidence concerns the gene TYR and Alzheimer disease.